In this on-demand webinar, FDA is providing background on investigational new drug (IND) safety reporting and will introduce listeners to the new guidance, "Sponsor Responsibilities—Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies". 

In this on-demand webinar, FDA is providing background on investigational new drug (IND) safety reporting and will introduce listeners to the new guidance, "Sponsor Responsibilities—Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies".